Mutations in the aryl hydrocarbon receptor interacting protein gene are not highly prevalent among subjects with sporadic pituitary adenomas

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 5, 2007, Pages 1952-1955

  Barlier, Anne ^a,b,c   Vanbellinghen, Jean François ^d   Daly, Adrian F ^d   Silvy, Monique ^b   Jaffrain Rea, Marie Lise ^e,f   Trouillas, Jacqueline ^g   Tamagno, Gianluca ^d   Cazabat, Laure ^h   Bours, Vincent ^d   Brue, Thierry ^a,c   Enjalbert, Alain ^b,c   Beckers, Albert ^d  

^a TIMONE HOSPITAL   (France)

^b HÔPITAL DE LA CONCEPTION   (France)

^c CNRS   (France)

^d UNIVERSITY OF LIÈGE   (Belgium)

^e UNIVERSITY OF L'AQUILA   (Italy)

^f Neuromed Istituto Mediterraneo Neurologico (IRCCS)   (Italy)

^g INSERM   (France)

^h Institut National de la Santé et de la Recherche Médicale U567 ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; DNA; ARYL HYDROCARBON RECEPTOR INTERACTING PROTEIN; ARYL HYDROCARBON RECEPTOR-INTERACTING PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; EXON; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE MUTATION; GENE SEQUENCE; GENETIC SCREENING; GERM LINE; HORMONE RELEASE; HUMAN; HYPOPHYSIS ADENOMA; LYMPHOCYTE; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROLACTINOMA; SOMATIC MUTATION; ADENOMA; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HYPOPHYSIS TUMOR; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA; MUTATION; PHYSIOLOGY;

ADENOMA; ADULT; DNA, NEOPLASM; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; MUTATION; PITUITARY NEOPLASMS; POLYMORPHISM, GENETIC; PROTEINS;

EID: 34249844498     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-2702     Document Type: Article

References (18)

1. Barlier A, Gunz G, Zamora AJ, Morange-Ramos I, Figarella-Branger D, Dufour H, Enjalbert A, Jaquet P 1998 Prognostic and therapeutic consequences of Gsα mutations in somatotroph adenomas. J Clin Endocrinol Metab 83:1604-1610
2. Landis CA, Masters SB, Spada A, Pace AM, Bourne HR, Vallar L 1989 GTPase inhibiting mutations activate the α chain of Gs and stimulate adenylyl cyclase in human pituitary tumors. Nature 340:692-696
3. Pei L, Melmed S 1997 Isolation and characterization of a pituitary tumor-transforming gene (PTTG). Mol Endocrinol 11:433-441
4. Zhao J, Dahle D, Zhou Y, Zhang X, Klibanski A 2005 Hypermethylation of the promoter region is associated with the loss of MEG3 gene expression in human pituitary tumors. J Clin Endocrinol Metab 90:2179-2186
5. Zhuang Z, Ezzat SZ, Vortmeyer AO, Weil R, Oldfield EH, Park WS, Pack S, Huang S, Agarwal SK, Guru SC, Manickam P, Debelenko LV, Kester MB, Olufemi SE, Heppner C, Crabtree JS, Burns AL, Spiegel AM, Marx SJ, Chandrasekharappa SC, Collins FS, Emmert-Buck MR, Liotta LA, Asa SL, Lubensky IA 1997 Mutations of the MEN1 tumor suppressor gene in pituitary tumors. Cancer Res 57:5446-5451
6. Kirschner LS, Sandrini F, Monbo J, Lin JP, Carney JA, Stratakis CA 2000 Genetic heterogeneity and spectrum of mutations of the PPKAR1A gene in patients with the Carney complex. Hum Mol Genet 9:3037-3046
7. Poncin J, Stevenaert A, Beckers A 1999 Somatic MEN1 gene mutation does not contribute significantly to sporadic pituitary tumorigenesis. Eur J Endocrinol 140:573-576
8. Kaltsas GA, Kola B, Borboli N, Morris DG, Gueorguiev M, Swords FM, Czirjak S, Kirschner LS, Stratakis CA, Korbonits M, Grossman AB 2002 Sequence analysis of the PRKAR1A gene in sporadic somatotroph and other pituitary tumors. Clin Endocrinol (Oxf) 57:443-448
9. Marx SJ, Simonds WF 2005 Hereditary hormone excess: genes, molecular pathways, and syndromes. Endocr Rev 26:615-661
10. Petrulis JR, Perdew GH 2002 The role of chaperone proteins in the aryl hydrocarbon receptor core complex. Chem Biol Interact 141:25-40
11. Harper PA, Riddick DS, Okey AB 2006 Regulating the regulator: factors that control levels and activity of the aryl hydrocarbon receptor. Biochem Pharmacol 72:267-279
12. Vierimaa O, Georgitsi M, Lehtonen R, Vahteristo P, Kokko A, Raitila A, Tuppurainen K, Ebeling TM, Salmela PI, Paschke R, Gundogdu S, De Menis E, Makinen MJ, Launonen V, Karhu A, Aaltonen LA 2006 Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science 312:1228-1230
13. Daly AF, Vanbellinghen J-F, Khoo SK, Jaffrain-Rea M-L, Naves LA, Guitelman MA, Murat A, Emy P, Gimenez-Roqueplo A-P, Tamburrano G, Raverot G, Barlier A, De Herder W, Penfornis A, Ciccarelli E, Estour B, Lecomte P, Gatta B, Chabre O, Sabaté MI, Bertagna X, Garcia Basavilbaso N, Stalldecker G, Colao A, Ferolla P, Wémeau J-L, Caron P, Sadoul J-L, Oneto A, Archambeaud F, Calender A, Sinilnikova O, Fajardo Montañana C, Cavagnini F, Hana V, Solano A, Delettieres D, Luccio-Camelo DC, Basso A, Rohmer V, Brue T, Bours V, Teh BT, Beckers A 2007 Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families. J Clin Endocrinol Metab 92:1891-1896
14. Daly AF, Jaffrain-Rea ML, Ciccarelli A, Valdes-Socin H, Rohmer V, Tamburrano G, Borson-Chazot C, Estour B, Ciccarelli E, Brue T, Ferolla P, Emy P, Colao A, De Menis E, Lecomte P, Penfornis F, Delemer B, Bertherat J, Wemeau JL, De Herder W, Archambeaud F, Stevenaert A, Calender A, Murat A, Cavagnini F, Beckers A 2006 Clinical characterization of familial isolated pituitary adenomas. J Clin Endocrinol Metab 91:3316-3323
15. Yu R, Bonert V, Saporta I, Raffel LJ, Melmed S 2006 AIP variants in sporadic pituitary adenomas. J Clin Endocrinol Metab 91:5126-5129
16. Barlier A, Pellegrini-Bouiller I, Gunz G, Zamora AJ, Jaquet P, Enjalbert A 1999 Impact of gsp oncogene on the expression of genes coding for Gsα, Pit-1, Gi2α, and somatostatin receptor 2 in human somatotroph adenomas: involvement in octreotide sensitivity. J Clin Endocrinol Metab 84:2759-2765
17. Reynaud R, Barlier A, Vallette-Kasic S, Saveanu A, Guillet MP, Simonin G, Enjalbert A, Valensi P, Brue T 2005 An uncommon phenotype with familial central hypogonadism caused by a novel PROP1 gene mutant truncated in the transactivation domain. J Clin Endocrinol Metab 90:4880-4887
18. Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G 2002 Relative quantification of 40 nucleic acid sequences by multiplex ligationdependent probe amplification. Nucleic Acids Res 30:e57